Essp Meditek Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 40 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -9.30%
- Profit Growth -124.57%
- Ebitda -94.18%
- Net Worth -0.71%
- Total Assets -13.60%
About Essp Meditek
Essp Meditek Pvt Ltd (EMPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 May 1984 and has a history of 40 years and nine months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shantanu Sathe, Suhasini Sathe, and Kedarnath Sathe serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH1984PTC032941
- Company No.
032941
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 1984
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Essp Meditek?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shantanu Sathe  | Director | 06-Mar-2010 | Current |
| Suhasini Sathe | Director | 17-Sep-1991 | Current |
| Kedarnath Sathe | Director | 06-Mar-2010 | Current |
Financial Performance of Essp Meditek.
Essp Meditek Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.3% decrease. The company also saw a substantial fall in profitability, with a 124.57% decrease in profit. The company's net worth dipped by a decrease of 0.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Essp Meditek?
In 2023, Essp Meditek had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sukeshan Equipments Pvt LtdShantanu Sathe, Suhasini Sathe and 1 more are mutual person
- Arbes Tools Private Limited
Shantanu Sathe, Suhasini Sathe and 1 more are mutual person
- Sukeshan Technologies Private Limited
Shantanu Sathe, Suhasini Sathe and 1 more are mutual person
- Stemone Biologicals Private Limited
Kedarnath Sathe is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Essp Meditek?
Unlock and access historical data on people associated with Essp Meditek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Essp Meditek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Essp Meditek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
